Praxis Precision Medicines’ challenge to Sage Therapeutics has unraveled. With a phase 2/3 clinical trial in major depressive disorder (MDD) failing comprehensively, Praxis is stopping work on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback